Enzymatics Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 70

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $114M

Enzymatics General Information

Description

Producer of enzymes intended for genomic sequencing machines. The company's products are used by commercial entities engaged in the development, enabling manufacturer with platforms dedicated to nucleic acid identification.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 100 Cummings Center
  • Suite 407J
  • Beverly, MA 01915
  • United States
+1 (978)
Primary Industry
Biotechnology
Acquirer
Corporate Office
  • 100 Cummings Center
  • Suite 407J
  • Beverly, MA 01915
  • United States
+1 (978)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enzymatics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 16-Dec-2014 $114M Completed Clinical Trials - Phase 1
3. Later Stage VC 14-Aug-2013 Completed Clinical Trials - Phase 1
2. Early Stage VC 01-Sep-2006 $1.6M $1.8M Completed Startup
1. Seed Round $200K $200K Completed Startup
To view Enzymatics’s complete valuation and funding history, request access »

Enzymatics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Producer of enzymes intended for genomic sequencing machines. The company's products are used by commercial entities eng
Biotechnology
Beverly, MA
70 As of 2015

Ipswich, MA
 

Somerville, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enzymatics Competitors (21)

One of Enzymatics’s 21 competitors is New England Biolabs, a Corporation company based in Ipswich, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
New England Biolabs Corporation Ipswich, MA
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Kanvas Venture Capital-Backed Monmouth Junction, NJ
Repligen Corporation Waltham, MA
Condalab Corporation Madrid, Spain
You’re viewing 5 of 21 competitors. Get the full list »

Enzymatics Patents

Enzymatics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150337364-A1 Isothermal methods and related compositions for preparing nucleic acids Inactive 27-Jan-2014
WO-2014071295-A1 Methods and kits for nucleic acid sample preparation for sequencing Inactive 02-Nov-2012
AU-2010314980-A1 Composition and method for synthesizing a deoxyribonucleotide chain using a double stranded nucleic acid complex with a thermostable polymerase Inactive 06-Nov-2009
CA-2779689-A1 Composition and method for synthesizing a deoxyribonucleotide chain using a double stranded nucleic acid complex with a thermostable polymerase Inactive 06-Nov-2009
EP-2496712-A1 Composition and method for synthesizing a deoxyribonucleotide chain using a double stranded nucleic acid complex with a thermostable polymerase Inactive 06-Nov-2009 C12Q1/6853
To view Enzymatics’s complete patent history, request access »

Enzymatics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enzymatics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Benevolent Capital PE/Buyout Minority
Keswick Ventures Venture Capital Minority
PBM Capital PE/Buyout Minority
To view Enzymatics’s complete investors history, request access »

Enzymatics Acquisitions (1)

Enzymatics’s most recent deal was a Merger/Acquisition with ArcherDX for . The deal was made on 06-Sep-2013.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
ArcherDX 06-Sep-2013 Merger/Acquisition Discovery Tools (Healthcare)
To view Enzymatics’s complete acquisitions history, request access »

Enzymatics FAQs

  • When was Enzymatics founded?

    Enzymatics was founded in 2006.

  • Where is Enzymatics headquartered?

    Enzymatics is headquartered in Beverly, MA.

  • What is the size of Enzymatics?

    Enzymatics has 70 total employees.

  • What industry is Enzymatics in?

    Enzymatics’s primary industry is Biotechnology.

  • Is Enzymatics a private or public company?

    Enzymatics is a Private company.

  • What is the current valuation of Enzymatics?

    The current valuation of Enzymatics is .

  • What is Enzymatics’s current revenue?

    The current revenue for Enzymatics is .

  • How much funding has Enzymatics raised over time?

    Enzymatics has raised $5.59M.

  • Who are Enzymatics’s investors?

    Benevolent Capital, Keswick Ventures, and PBM Capital have invested in Enzymatics.

  • Who are Enzymatics’s competitors?

    New England Biolabs, Genetix Biotherapeutics, Kanvas, Repligen, and Condalab are some of the 21 competitors of Enzymatics.

  • When was Enzymatics acquired?

    Enzymatics was acquired on 16-Dec-2014.

  • Who acquired Enzymatics?

    Enzymatics was acquired by Qiagen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process